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Introduction: As genetics become increasingly incorporated into healthcare, the role of 
primary care providers (PCPs) in diagnosing and caring for people with genetic conditions will 
continue to grow. However, many PCPs do not feel they have adequate resources to be successful 
in this role. This project looked at usage of the ACTion (ACT) Sheets, a “just-in-time” reference 
resource made by the American College of Medical Genetics (ACMG) in collaboration with the 
National Coordinating Center for Regional Genetics Networks (NCC). ACT Sheets provide a one-
page summary of over 80 genetic conditions. These fact sheets include information relevant to 
PCPs such as differential diagnosis, next steps, potential referrals, and available management 
options. By making this information available to PCPs, development and marketing of the ACT 
Sheets fall under the third essential public health service – Inform, Educate, Empower. 
Methods: This project analyzed website usage statistics from the ACMG webpage where 
the ACT Sheets are posted. Access information by state was then compared to PCP density in each 
state to explore whether the ACT Sheets were being used as expected. Overall usage was compared 
to the schedule of conferences where NCC staff promoted the ACT sheets to determine if this 
impacted actual ACT Sheet usage. Responses to a brief survey regarding frequency of use and 
satisfaction with the ACT Sheets were also analyzed. 
v 
 
Results/Conclusions: Visitors to the webpage were from all 50 states. There was a direct 
relationship between the state population or number of PCPs and number of visits. For impact of 
promotional activities at conferences, there was evidence for higher ACT Sheet usage in months 
where the NCC attended at least one conference. Most survey respondents were satisfied with the 
ACT Sheets and reported using the resources more than once a year.  
Limitations: The ACMG website is a public website, so it is possible that a significant 
number of visitors to the ACT Sheet page and respondents to the survey were not PCPs. The 
website usage data was also pulled from the main page displaying the ACT Sheets, so it may not 
represent how often individual ACT Sheets were viewed. 
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1.0 Introduction 
Initially incorporated in 1991, the American College of Medical Genetics and Genomics 
(ACMG) began as a way to create a national platform for healthcare providers involved in the 
emerging field of medical genetics to collaborate and be represented. In 2001, a cooperative 
agreement was made between ACMG and the Maternal and Child Health Bureau within the Health 
Resources and Services Administration (HRSA) branch of the federal Department of Health and 
Human Services. This agreement resulted in the formation of the National Coordinating Center for 
the Regional Genetics Networks (NCC) (American College of Medical Genetics and Genomics, 
n.d.-a; National Coordinating Center for the Regional Genetics Networks, n.d.-a). Together, the 
NCC and ACMG created ACTion (ACT) Sheets, a “just-in-time” resource to which primary care 
providers (PCPs) can refer when one of their patients either seems to be presenting with a genetic 
condition or has a genetic diagnosis already (American College of Medical Genetics and 
Genomics). The ACT Sheets work toward the two organizations’ different but related goals. The 
ACMG’s current goals are to “engage in coordinated efforts to improve patient care, ensure 
optimal reimbursement for genetic service providers, establish standards of care and laboratory 
policy, and educate members about advances important to their practices” (American College of 
Medical Genetics and Genomics, n.d.-a). The NCC’s overarching goal is to “bring genetic services 
closer to local communities” (National Coordinating Center for the Regional Genetics Networks, 
n.d.-a). 
More specifically, the NCC achieves its goal by supporting seven regional networks 
covering the United States: 1) Heartland Regional Genetics Network, 2) Midwest Regional 
Genetics Network, 3) Mountain States Regional Genetics Network (MSRGN), 4) New England 
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Regional Genetics Networks (NERGN), 5) New York Mid-Atlantic Consortium Regional 
Genetics Network (NYMAC), 6) Southeast Regional Genetics Network (SERN), 7) Western 
States Regional Genetics Network (WSRGN). The NCC’s primary ways of supporting the regional 
networks are promoting a nation-wide infrastructure that can support an increase in genetic 
services usage in an equitable way, working with regional networks to create quality improvement 
programs, making recommendations regarding delivery and financing of genetic health services, 
and providing technical support (National Coordinating Center for the Regional Genetics 
Networks, n.d.-a). As of 2017, the NCC also works with the National Genetics Education and 
Family Support Center (NGEFSC) – a three-year initiative seeking to improve access to quality 
genetic services by building networks of partners, including people with genetic conditions and 
their families (National Coordinating Center for the Regional Genetics Networks, n.d.-b) 
Currently, the ACT Sheets are being promoted by the National Coordinating Center for 
Regional Genetics Networks through their website and social media, the ACMG website, and 
through direct communication at conference booths. The ACT Sheets are also available on 
websites such as the National Library of Medicine and Up-to-Date that would be more commonly 
used by non-genetics professionals (American College of Medical Genetics and Genomics, 2001; 
UpToDate, n.d.). 
It is well established that PCPs often do not have the knowledge base necessary to provide 
information on genetics and genetic conditions or make all the proper referrals (Bellcross et al., 
2011; Cohn et al., 2015; Cragun, Scherr, Camperlengo, Vadaparampil, & Pal, 2016; Dekanek et 
al., 2020; Hayeems et al., 2013; Kemper, Uren, Moseley, & Clark, 2006; Moeller, White, & 
Shisler, 2006; Nair et al., 2017; Oyeku, Feldman, Ryan, Muret-Wagstaff, & Neufeld, 2010; Pal et 
al., 2013; Vickery et al., 2014). This is problematic, especially given the critical role of PCPs in 
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identifying patients who could benefit from genetic care (Harding et al., 2019b; Nair et al., 2017; 
Paneque et al., 2016). There is also a high likelihood for PCPs to interact with a patient where 
genetics plays a role in their health at some point in their career, due to an estimated 10-percent of 
people having a condition that is caused, or at least influenced, by a genetic factor (Paneque et al., 
2016). This is where “just-in-time” resources about genetics, like ACT Sheets can be useful as 
they provide a brief overview of pertinent information for PCPs to quickly review when seeing a 
patient who has or may have an included genetic condition. The ACT Sheets’ content will therefore 
ideally help PCPs make informed decisions about patient care by giving them information such as 
common characteristics of the genetic condition under consideration and potential referrals to 
make. Although there is some necessary variation between sheets, the typical ACT Sheet 
accomplishes this transfer of information by including sections such as Differential Diagnosis, 
Condition Description, Actions to Take, Diagnostic Evaluation, and Clinical Considerations, as 
well as including links to additional information (American College of Medical Genetics and 
Genomics).  
As of May 2019 , there had been little, if any, analysis of whether the ACT Sheets were 
reaching PCPs and functioning as intended. The goal of this project is to begin to elucidate the 
extent to which ACT sheets are achieving this by analyzing usage data collected by the NCC. One 
aspect of the data is a three-question survey posted on the main page of the ACT Sheets and 
Algorithms page on the ACMG website. The survey was designed to pop-up upon a user entering 
the page. The survey data include information on users’ satisfaction with the ACT Sheets. Survey 
responses were collected between August 2018 and May 2019. The other aspect of the data are 
web analytics that were pulled between August 2018 and August 2019. The web analytics data 
include users’ geographic location – broken down by country or US state – when they access the 
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ACT Sheets, the number of times the pages have been visited, and the number of unique visitors 
versus return visitors. The number of times the pages have been visited was also broken down into 
visits per month and compared to a timeline of conferences attended by NCC staff where ACT 
sheets would have been promoted to determine the impact of such promotion on usage. 
1.1 Specific Aims 
• Analyze data on the usage of ACT Sheets collected via a short online survey 
conducted by the ACMG and web analytics from the main ACT Sheets page to: 
o Determine if marketing of the ACT Sheets impacts their usage by tracking 
usage trends over time in relation to various marketing efforts. 
o Assess potential barriers to ACT Sheet usage by comparing actual usage to 
expected usage based on regional density of healthcare providers 
throughout the United States. 
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2.0 Primary Care and Genetics: Educational Needs and Approaches 
Although primary care providers (PCPs) play a vital role in identifying patients who would 
benefit from consideration of a genetic diagnosis, or even a formal genetics consult (Hamilton et 
al., 2017; Harding et al., 2019b), there is still some debate about how much they can be expected 
to know given their broad scope of practice. Studies have found mixed results regarding the 
perspectives of PCPs toward integrating genetics into their regular practice; typically, most 
participants are in favor of its inclusion, but there are always at least a few who are either opposed 
or are in favor but with clear reservations (Harding et al., 2019a; Harding et al., 2019b).  
2.1 Role in Genetic Care 
The World Health Organization defines primary care as a field that provides 
comprehensive care to people across various stages of life and disease categories (World Health 
Organizaton, 2019). This encompasses both prevention and treatment of a wide variety of diseases, 
including genetic disorders and predispositions. 
Specifically regarding genetic care, a publication by Harding et al. explains the role of a 
PCP in genetic care from the perspective of PCPs themselves. These roles included: taking family 
histories and assessing risk, building care plans based on this information, and making referrals to 
genetics if deemed appropriate, as well as educating their patients about the ethical and 
psychosocial impacts of genetics – not just the medical implications (Harding et al., 2019b). A 
separate publication by Harding et al. defined a tiered model based on the perspectives and comfort 
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levels of twenty-three PCPs, as provided during interviews and focus groups. In this model, there 
are four stages: reassuring low-risk patients, educating patients about basics of genetic testing and 
ordering the applicable test, remaining involved in more complex cases, and knowing when a 
patient should be referred for formal genetics consult. The PCP’s level of comfort and confidence 
in their genetic knowledge influences at which stage a PCP can fall (Harding et al., 2019a). 
2.1.1 Newborn Screening 
PCPs also have a role to play in newborn screening (Almannai, Marom, & Sutton, 2016; 
Caggana et al., 2013). Newborn screening in the United States began in 1963 after Robert Guthrie 
and Ada Susi published a bacterial inhibition assay to screen for phenylketonuria (PKU) using 
dried blood spots (Almannai et al., 2016; Caggana et al., 2013; Guthrie & Susi, 1963). Since then, 
numerous new screening tests have been developed and implemented to increase the early 
diagnosis of treatable conditions that would be severely life-altering and sometimes lethal without 
early interventions (Almannai et al., 2016). Screening is done by collecting a small amount of a 
newborn’s blood through a heel prick completed within the first 24 to 48 hours of their life. This 
blood sample is stored on a specialized paper card, which is then sent out to a laboratory that 
conducts the actual newborn screening tests (Caggana et al., 2013).  
The general criteria for adding conditions to newborn screening, as established by the 
National Academy of Sciences include: having the means to appropriately screen for each 
condition, cost-effectiveness, available treatments and educational resources to allow diagnosis to 
improve quality of life, and an overall benefit to and acceptance by the general public (Caggana et 
al., 2013). However, conditions are added to newborn screening on a state-by-state basis, in 
relation to the unique needs of each state’s population, the state’s financial and technological 
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capabilities, and state politics (Almannai et al., 2016; Caggana et al., 2013). This leads to variation 
in the number and types of conditions screened for between states. In the early 2000s, this was 
recognized to be a concern, which led to the formation of an American College of Medical 
Genetics (ACMG) taskforce responsible for creating a list of recommended conditions (Caggana 
et al., 2013). This list would develop into the Recommended Uniform Screening Panel (RUSP), 
which is now managed by the Health and Human Resources Administration’s (HRSA’s) Advisory 
Committee on Heritable Disorders in Newborns and Children (Almannai et al., 2016; Caggana et 
al., 2013). The RUSP currently consists of 35 core conditions, and 26 secondary conditions that 
may be found in the process of screening for the core conditions (Health Resources and Services 
Administration). 
In the event of an abnormal result, the provider and birthing facility listed on the newborn’s 
card will be contacted and be expected to communicate these results to the newborn’s parents 
effectively (Almannai et al., 2016; Caggana et al., 2013). This expectation can be problematic 
because many of the conditions included in newborn screening are rare, and therefore many 
providers are not well-versed in the nuances of management of these conditions or their prognoses 
(Almannai et al., 2016). Providers who are not completely confident in their baseline knowledge 
have reported using the internet or fact sheets to refresh their memory (Finan, Nasr, Rothwell, & 
Tarini, 2015), suggesting that easy to access, internet-based just-in-time resources can be useful 
during this time (Moeller et al., 2006). In a survey of family physicians and pediatricians, a 
significant proportion of providers were not confident in their knowledge of newborn screening 
and ability to explain it to parents, with 18.5% of family physicians and 57.8% of pediatricians 
reporting they were up to date on newborn screening (Hayeems et al., 2013). This difference in 
knowledge base between pediatricians and family physicians is also reported elsewhere in the 
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literature. A nationwide study found pediatricians typically reporting higher levels of confidence 
and competence compared to family physicians in explaining newborn screening and included 
conditions (Kemper et al., 2006). A Massachusetts-based study that assessed PCP knowledge and 
confidence regarding newborn screening for hemoglobinopathies found that even when knowledge 
was increased by educational interventions, confidence did not increase significantly (Oyeku et 
al., 2010). Additional barriers, such as time constraints, have also been reported, although the 
majority of providers report that they are responsible for providing education on newborn 
screening (Hayeems et al., 2013; Kemper et al., 2006; Oyeku et al., 2010). A lack of confidence 
can translate into use of medical jargon instead of the patient-friendly language that becomes 
especially necessary for parent understanding during the potentially stressful and emotional time 
following a positive screen (Finan et al., 2015). Interviews of 14 PCPs in Michigan showed that 
some providers were unsure of the next steps following a positive newborn screen for cystic 
fibrosis. None of the interviewed providers had undergone any formal training in discussing these 
results with families and several reported struggling with how much information to provide the 
family prior to confirmatory testing and difficulty in answering parents’ questions (Finan et al., 
2015).  
2.2 Need for Genetics Education 
As PCPs are often the first contact for patients at risk for a genetic condition, it is important 
that PCPs are able to recognize telltale signs of genetic conditions (Harding et al., 2019b; Nair et 
al., 2017; Paneque et al., 2016). However, many PCPs lack essential skills, such as taking a family 
history and using it to assess whether a genetic condition seems likely (Cragun et al., 2016; Nair 
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et al., 2017; Scheuner et al., 2014). This results in people with genetic conditions remaining 
undiagnosed, and therefore untreated, which can lead to increased mortality from what would 
otherwise be a manageable or preventable disease (Harding et al., 2019b; Nair et al., 2017; Vickery 
et al., 2014). This includes HBOC, where misconceptions are prevalent about the possibility of a 
man to carry a pathogenic variant and have increased breast cancer risks. Among PCPs, one study 
showed that only 34.5-percent of respondents knew that, when assessing a patient’s family history, 
their paternal family could be equally as important as their maternal family, and only just over half 
of respondents knew that males who have breast cancer are at increased risk for carrying a 
pathogenic variant related to HBOC (Cohn et al., 2015). Pal et al. (2013) found that although their 
respondents had a better understanding regarding paternal inheritance of a BRCA1 pathogenic 
variant (95-percent correct), only just over half of respondents correctly answered that less than 
10-percent of women with breast cancer will have a BRCA1 or BRCA2 pathogenic variant (Pal et 
al., 2013), which could lead to over-referral of lower risk patients. Another study assessed PCP’s 
ability to correctly identify individuals at increased risk for HBOC based on family history and 
stratified their results by PCPs who were aware of BRCA1 and BRCA2 testing, but had never 
ordered it and PCPs who had ordered testing. They found that several PCPs (39-percent who had 
not ordered and 45-percent who had ordered) selected at least one low-risk family history for 
testing and few (15-percent who had not ordered and 19-percent who had ordered) correctly chose 
only the high-risk family histories (Bellcross et al., 2011). 
Even within conditions on newborn screening, PCPs are not always aware of all the 
appropriate referrals following confirmation of a diagnosis. A Massachusetts-based study focused 
on PCP knowledge and practices surrounding sickle cell anemia found that 67% of participants 
referred patients with sickle cell disease to a specialist such as a hematologist or genetic counselor, 
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while only 20% referred patients with sickle cell trait even though these families could benefit 
from genetic counseling as well. Further, 41% of PCPs reported never discussing the implications 
for current and future pregnancies of previously having a child with sickle cell disease (obligate 
carrier status) with pregnant mothers who fall in this category (Oyeku et al., 2010). Interestingly, 
another study reported that a subset of PCPs (19.4% of pediatricians and 12.6% of family 
physicians) would refer a family to genetics following identification of a newborn carrier of cystic 
fibrosis, but not a newborn with sickle cell trait, even though both groups of people are carriers for 
a recessive condition with significant impact on health (Kemper et al., 2006). Similarly, for infants 
found to have hearing loss upon newborn hearing screening, the majority of PCPs (75.8%) make 
the necessary referral to an otolaryngologist, but very few refer families to genetics (8.9%) or 
ophthalmology, (0.9%) even though these are both relevant referrals due to the increased incidence 
of an underlying genetic factor or vision difficulties in people with congenital hearing loss. 
(Moeller et al., 2006). In contrast, a nationwide study found that 50% of PCPs would refer an 
infant diagnosed with congenital hypothyroidism to genetics, even though such a referral is not 
routinely recommended or necessary (Kemper et al., 2006). 
It is important to note that it is not only people with rare genetic conditions who are 
undiagnosed. Individuals with relatively common conditions, such as familial 
hypercholesterolemia (FH) and hereditary breast and ovarian cancer (HBOC), are also at risk of 
going undiagnosed (Nair et al., 2017; Vickery et al., 2014). This is concerning due to the high 
number of people who could be helped if correct diagnoses were made for these conditions more 
often because of the changes in management that can be made to improve outcomes. In the case 
of FH, a diagnosis would help delay the onset of cardiac disease, which would usually occur at an 
abnormally young age in an untreated individual with FH, through the use of cholesterol lowering 
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medications (Vickery et al., 2014).  In the case of HBOC, a diagnosis can lead to heightened 
surveillance for breast cancer in order to find and treat tumors at early stages. If the patient is not 
planning to have any more children, an HBOC diagnosis can also come with recommendations for 
a salpingo-oophorectomy, the removal of the ovaries and fallopian tubes, to help minimize the 
patient’s risk of ovarian cancer (National Comprehensive Cancer Network, 2020), due to the 
current lack of effective screening for ovarian cancer (Henderson, Webber, & Sawaya, 2018). 
Cascade screening, which is testing first-degree relatives of individuals carrying a mutation, can 
also be done in both FH and HBOC to improve early diagnosis rates, and therefore improve overall 
health (Nair et al., 2017; Vickery et al., 2014).  
There is also the issue of decreased confidence among PCPs in regard to providing genetic 
care. A questionnaire-based study looking at PCP knowledge and confidence in genetic testing for 
common chronic diseases found that only 40-percent of respondents felt knowledgeable on the 
genetics of common diseases. Further, only 25- and 28-percent of respondents, respectively, felt 
comfortable working with patients with prior genetic testing and patients who are at increased risk 
for a genetic condition, and only 14-percent felt comfortable discussing genetic test results with 
their patients (Hauser, Obeng, Fei, Ramos, & Horowitz, 2018). A questionnaire-based study of 
PCP knowledge and confidence regarding HBOC found that very few (less than six percent) of 
respondents felt completely confident in any one of several components of a discussion of HBOC: 
BRCA1/2 cancer risks, inheritance pattern, result interpretation, and testing methods. None of the 
respondents felt completely confident discussing management changes in the event of a positive 
genetic result (Dekanek et al., 2020). 
Continuing to use PCP knowledge of HBOC as an example, a survey-based study of family 
medicine physicians and obstetricians/gynecologists found that although the majority of 
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respondents correctly identified the definition of a variant of uncertain significance (VUS), 70-
percent of respondents stated that they would recommend familial variant testing for a VUS 
(Dekanek et al., 2020). Similar misconceptions regarding testing for VUS in hereditary cancer 
predispositions have been reported elsewhere in the literature (Pal et al., 2013). This same group 
also found that 44-percent of respondents failed to choose the correct genetic testing for someone 
with a relative who has tested positive for a pathogenic variant in BRCA1 or BRCA2 and that only 
about half of respondents correctly identified the inheritance pattern of HBOC (Dekanek et al., 
2020).  
2.3 Approaches to Genetic Education 
Overall, research has found that PCPs are aware of the limits of their knowledge on genetics 
and are open to learning more about relevant topics within genetics (Hamilton et al., 2017). The 
main approaches to educate primary care providers about genetic principles that have been 
discussed in the literature are continuing education courses (Houwink et al., 2015; Jackson et al., 
2019; Scheuner et al., 2014; Telner et al., 2017) and just-in-time resources (Harding et al., 2019a; 
Harding et al., 2019b; Jackson et al., 2019; Scheuner et al., 2014). Each of these have their own 
strengths and weaknesses which will be discussed in the following sections. Alternative options, 
such as using practice tools that guide decision making in real-time have also been discussed and 
are usually part of a larger, multi-pronged educational approach (Scheuner et al., 2014). 
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2.3.1 Continuing Education 
Continuing education is the most commonly discussed approach in the literature in regard 
to educating PCPs about current practices in genetics. Houwink et al. organized a continuing 
education course with an online option and an in-person option, paired with a supplementary 
website with continually updated information (Houwink et al., 2015). They measured the success 
of their program through a combination of a questionnaire requesting self-reports of genetics-
related skills used in practice and a pop-up survey assessing satisfaction with the supplementary 
website. Through this, they found that PCPs who attended the in-person course were more likely 
to consider referring to a genetics specialist than PCPs who completed the online version, but both 
were more likely to consider referring after the course than they were before. Increased 
consideration of referrals did not translate into an increased number of referrals, however. This 
may be because more accurate referrals are being made due to the course improving knowledge of 
genetic risk among PCPs, which would further support success of this program. Additionally, 
positive feedback from their website’s pop-up survey suggests that supplementing a continuing 
education course with a website in this manner is positively received by PCPs and improves 
translation of new skills into their daily practice (Houwink et al., 2015).  
Telner et al. used a randomized control trial structure to assess if there is a difference in 
educational impact between traditional, in-person lectures and online modules for educating PCPs 
in genetics (Telner et al., 2017). Overall, each education group reported that they enjoyed their 
course and found it effective, but for different reasons. The group that attended in-person lectures 
appreciated the immediate feedback they received from fellow learners, instructors, and the 
standardized patients that were included as part of the learning process. They also commented on 
the fact that this structure allowed them to reinforce their new knowledge by using it first-hand 
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with the standardized patients. The group that completed the online modules reported that they 
valued the flexibility of being able to review material and complete coursework at their own pace, 
as well as the benefit of being able to look back at previously studied material at any point. The 
main aspect they reported they would like to have added was a way to discuss concepts being 
covered with fellow learners, such as through an online forum linked to the course (Telner et al., 
2017). However, they did not find a significant difference in actual learning outcomes between the 
online and in-person methods. This is important because online resources are less expensive to 
produce and distribute and also easier for providers in remote areas to access (Telner et al., 2017), 
suggesting that they may be more beneficial than in-person programs. 
2.3.2 “Just-in-Time Resources” 
“Just-in-time” resources are resources that are intended to be reference tools for clinical 
decision-making support, rather than comprehensive education on a given topic. As brief internet-
based fact sheets on a variety of genetic conditions that include information to guide clinical 
decision making, the ACMG ACTion (ACT) Sheets are one example of a “just-in-time” resource. 
They can be found on the ACMG website, as well as other commonly used websites such as Up-
to-Date and the National Library of Medicine (American College of Medical Genetics and 
Genomics, 2001; UpToDate, n.d.). There is evidence that such “just-in-time” resources are well-
received by PCPs, as long as they are easily accessible (Harding et al., 2019a). Many of the 
participants in a study conducted by Harding et al. mentioned the value of electronic resources 
where PCPs can access information about various genetic conditions as needed. This could include 
information to support clinical decision making about proper referrals. They quoted one participant 
talking about “websites where they can easily obtain the information and access what the next best 
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steps should be” (Harding et al., 2019a, p. 5). This aligns with the goal of the ACT Sheets, 
especially considering that each ACT Sheet contains a section detailing next steps to take, 
including any recommended referrals, for the given condition (American College of Medical 
Genetics and Genomics). The question remains, however, whether the ACT Sheets are as easily 
accessible as PCPs need them to be in order for the ACT Sheets to achieve this goal. 
These “just-in-time” resources may also be beneficial in situations where a PCP is not as 
invested in taking the time to learn the details of genetic conditions. Harding et al. quoted another 
participant as saying, “Remembering the details is not all that important as long as you remember 
there is some aid. There is a piece of paper that… will give me some information about what to do 
with patients with genetic… issues” (Harding et al., 2019a, p. 5). Admittedly, this is an 
understandable viewpoint given the broad scope of what PCPs are required to manage regularly. 
However, from a genetic care standpoint, the concern here is whether or not having this 
preliminary level of understanding will be enough to recognize when a genetic condition should 
be considered to allow the appropriate next steps, including referrals to be made. 
Harding et al. also mention a lack of up-to-date reference materials as a barrier to PCPs 
being involved in genetic care (Harding et al., 2019b). This is another area where “just-in-time” 
resources, such as the ACT Sheets, could potentially be useful, as long as they are well-maintained 
and regularly updated to keep up with the rapidly changing field of genetics. 
2.3.2.1 ACT Sheets - Newborn Screening & More 
The breadth of the ACT Sheets is rapidly expanding as new ACT Sheets are developed to 
cover new conditions and new categories. Initially, there were only ACT Sheets for conditions 
included in newborn screening (American College of Medical Genetics and Genomics).  The ACT 
Sheets in this category are closely related to conditions listed on the Recommended Uniform 
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Screening Panel (RUSP). However, there are some additional conditions included in the ACT 
Sheets that are not on the RUSP, as well as other conditions that were recently added to the RUSP 
and do not have corresponding ACT Sheets yet. An example of a condition not listed on the RUSP 
that has an ACT Sheet is ornithine transcarbamylase (OTC) deficiency (American College of 
Medical Genetics and Genomics, n.d.-b). Examples of conditions that were recently added to the 
RUSP but did not have corresponding ACT Sheets at the time this project began are X-linked 
adrenoleukodystrophy (X-ALD) and spinal muscular atrophy (SMA), which were added to the 
RUSP in 2015 and 2018 respectively. Notably, there are ACT Sheets for five different lysosomal 
storage disorders, while the only lysosomal storage disorder listed on the RUSP is Pompe Disease 
(American College of Medical Genetics and Genomics; Health Resources and Services 
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• Argininemia Yes Secondary  
Increased  
Citrulline 
• Citrullinemia I 
• Arginosuccinic 
Acidemia 
• Citrullinemia II  
(citrin deficiency) 




































Table 1. Current ACMG Newborn Screening ACT Sheets 
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• Maple syrup urine 
disease (MSUD) 
Yes Primary  
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Table 1. Current ACMG Newborn Screening ACT Sheets 
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Table 1. Current ACMG Newborn Screening ACT Sheets 
  Endocrine 
Disorders 
Elevated TSH • Primary congenital 
hypothyroidism 
Yes Primary  
Low T4 +/- 
Elevated TSH 
• Primary and secondary 
congenital 
hypothyroidism 












• Congenital adrenal 
hyperplasia (CAH) 




Decreased C0  
and other 
acylcarnitines 
• Carnitine uptake defect 
(CUD) 
Yes Primary  
Elevated 
C0/C16+C18 
• Carnitine palmitoyl 
transferase I deficiency 
(CPT1) 
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Table 1. Current ACMG Newborn Screening ACT Sheets 
   Elevated  




































Yes Secondary  


























• Very long-chain acyl-
CoA dehydrogenase 
(VLCAD) deficiency 
Yes Primary  
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• Biotinidase deficiency Yes Primary Present on 
another ACT 





Hypoxemia • Critical congenital 
heart disease (CCHD) 
Yes Primary  
Elevated IRT 
+/- DNA 




• Congenital Hearing 
Loss 
Yes Primary  
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• Homozygous sickle 
cell disease (HbSS) 
• Sickle beta-zero 
thalassemia (HbSβ0 
Disease) 
• Sickle hereditary 


















grouping it with 
HbSβ + Disease   
Hemoglobin 
FSC 
• Hemoglobin SC 
Disease (HbSC) 
Yes Primary  
Hemoglobin 
FSA 
• Hemoglobin S/Beta 
plus Thalassemia 
(HbSβ + Disease) 
Yes Primary RUSP lists this 
as “S, Beta-
Thala-ssemia,” 
grouping it with 
HbSβ0 Disease   
Hemoglobin 
FAS 
• Sickle Cell 
Carrier/Trait 
**   
Hemoglobin 
FAV 
• Hemoglobin Variant 
Carrier 
**   
Hemoglobin 
FEA 
• Hemoglobin E/Beta 
Plus Thalassemia 
(HbE/ + Disease) 
**   
**Indicates that the condition is grouped by the RUSP under “various other hemoglobinopathies” as part of the secondary conditions 
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• Homozygous beta 
thalassemia 
(thalassemia 
intermedia or major) 
• Hereditary persistence 








FA + Barts 
Hb 
• Hemoglobin A/Barts 
• Alpha thalassemia 
carrier 
• Hemoglobin H disease 










hemoglobin C (HbCC 
Disease) 
• Hemoglobin C/beta 
zero (β0) thalassemia 
• Hereditary persistence 









**Indicates that the condition is grouped by the RUSP under “various other hemoglobinopathies” as part of the secondary conditions 
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Table 1. Current ACMG Newborn Screening ACT Sheets 
 Hemoglobin 
FCA 
• Hemoglobin  C/Beta 
Plus Thalassemia 
(HbC/β + Disease) 
**   
Hemoglobin 
FEA 
• Hemoglobin E/Beta 
Plus Thalassemia 
(HbE/ + Disease) 





• Severe Combined 
Immunodeficiency 
(SCID) and Conditions 
Associated with T-Cell 
Lymphopenia  

















• Fabry Disease No   
- • Gaucher Disease No   
- • Krabbe Disease No   
- • Niemann-Pick Disease 
Type A and B 
No   
- 
• Pompe Disease 
(Glycogen Storage 
Disease Type II) 
Yes Primary  
**Indicates that the condition is grouped by the RUSP under “various other hemoglobinopathies” as part of the secondary conditions 
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• Glutaric aciduria  
(GA-1) 
Yes Primary  
Elevated C5 
Acylcarnitine 























Yes Secondary  
Elevated C3 
Acylcarnitine 

























Table 2. Primary conditions on the RUSP without ACT Sheets 
3-Methylcrotonyl-CoA Carboxylase Deficiency 
3-Hydroxy-3-Methyglutaric Aciduria 
Mucopolysaccharidosis Type 1 
X-linked Adrenoleukodystrophy 
Spinal Muscular Atrophy 
(due to homozygous deletion of exon 7 in SMN1) 
 
Now that the breadth of the ACT Sheets’ coverage has grown, there are ACT Sheets on the 
topics of carrier screening, diagnostic testing, family history considerations, transitioning care 
from pediatric to adult providers for individuals who have genetic conditions, and – the most recent 
addition – handling secondary findings. The original section on newborn screening is still by far 
the largest with a total of 50 ACT Sheets between its nine sub-categories, while the newer sections 
collectively include twenty-seven ACT Sheets.  The secondary findings section, especially, is 
expected to grow to eventually cover the entire ACMG 59 (M. Lyon, personal communication, 
2019). The ACMG 59 is a list of 59 genes for which the ACMG recommends returning results to 
patients in cases where a pathogenic variant happens to be found through a genetic test that was 
not specifically looking at these genes. The recommendations are based on the penetrance of 
pathogenic variants in these genes and whether there is a medical benefit, such as an available 
treatment, to the patient knowing they carry a pathogenic variant in one of these genes (Kalia et 
al., 2017). Currently, the ACT Sheets cover four out of these 59 genes (American College of 
Medical Genetics and Genomics; Kalia et al., 2017).  
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2.3.3 Combinatory Approach 
The online Gen-Equip project created by Jackson et al. combined case-based continuing 
education modules, pre-recorded webinars, guidelines, practice tools, and links to other pertinent 
online resources to promote genetic knowledge in PCPs. The information covered by these online 
materials included various categories of genetic conditions, how to take a family history, when to 
make a referral, and how to talk to patients about genetics (Jackson et al., 2019). After surveying 
80 people spread across multiple countries, they found that the majority of users were satisfied 
with the resources and information based on clarity of its presentation, its accessibility, and its 
relevance to primary care. However, it is important to note that this may be biased due to the fact 
that PCPs who used this resource would have already had a pre-existing interest in incorporating 
genetics into their practice. They also only had 80 respondents when there were over 7,000 people 
who visited the Gen-Equip website in total (Jackson et al., 2019). In addition to user satisfaction, 
they saw significant improvement in user knowledge based on average improvements of over 20 
percent between pre- and post-test scores across all continuing education modules. They also saw 
improvements in user confidence and changes in practice behaviors, including being more likely 
to take a family history and placing more value on the patient’s perspective of testing. These latter 
results were based on interviewing 21 people who successfully completed at least one of the 
continuing education modules (Jackson et al., 2019). 
Instead of an online system, Scheuner et al. used a clinic-based combinatory approach that 
involved a series of in-person lectures, patient- and provider-facing fact sheets, links to internal 
and external resources within their electronic health record system, a pop-up reminder to take a 
family history with built-in questions to guide decision-making regarding follow-up, and a form 
about family history that patients could fill out while waiting for their appointments. Feedback 
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from providers in the clinic varied for each aspect of the approach (Scheuner et al., 2014). The 
pop-up reminder was the most popular, followed by the lecture series and patient-facing sheets. 
The least frequently used resources were the links to internal and external resources, due to 
providers not having enough time to access and review this content during patient appointments 
as intended (Scheuner et al., 2014). This is important because a similar barrier may also be present 
in accessing the ACT Sheets, especially if a provider does not know to consider a condition prior 
to meeting with the patient. 
2.4 Importance to Public Health 
Within public health, there are ten essential services, as defined by the CDC: “1) monitor 
health status to identify and solve community health problems, 2) diagnose and investigate health 
problems and health hazards in the community, 3) inform, educate, and empower people about 
health issues, 4) mobilize community partnerships and action to identify and solve health 
problems, 5) develop policies and plans that support individual and community health efforts, 6) 
enforce laws and regulations that protect health and ensure safety, 7) link people to needed personal 
health services and assure the provision of health care when otherwise unavailable, 8) assure 
competent public and personal health care workforce, 9) evaluate effectiveness, accessibility, and 
quality of personal and population-based health services, 10) research for new insights and 
innovative solutions to health problems” (Centers for Disease Control and Prevention, n.d.). 
The development and marketing of the ACT Sheets fall under the third essential service– 
“Inform, Educate, Empower” – because of their goal of promoting a workforce of healthcare 
professionals who are capable of working with people who have indications or a diagnosis of a 
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genetic condition through just-in-time education. The ACT Sheets are also related to the seventh 
essential service – Link to and Provide Care – in that they provide a reference resource for primary 
care providers and other non-genetics professionals. The bulleted section included on the majority 
of ACT Sheets describing next steps these providers need to take is especially relevant to this 
essential service as it often includes referrals or consults that need to be made, as well as other 
concrete steps a provider can take in providing care to a patient with a given disease that is covered 
by an ACT sheet (American College of Medical Genetics and Genomics). 
This alignment with the accepted ten essential public health services highlights the 
importance of having a sound system for educating PCPs and other non-genetics healthcare 
professionals about basic genetic concepts so they can make informed decisions on how to treat or 
refer their patients. There is an unacceptable number of people who go undiagnosed with genetic 
conditions, such as genetic predispositions to cancer that are addressed by some of the newer ACT 
sheets, who experience preventable complications later in life (Harding et al., 2019b). The risk of 
this happening can be greatly diminished by educating non-genetics healthcare professionals on 
how to recognize such situations and act accordingly or make the appropriate referrals to genetic 
services. 
The ACT Sheets are one small part of a much larger system that needs to be in place in 
order for more people to be aware of their potentially actionable genetic diagnoses. However, 
looking at what has worked for resources like the ACT Sheets in the past could inform future 
efforts to communicate genetic information to non-genetics healthcare professionals. 
This study in particular used a three-question anonymous survey completed by visitors to 
the page within the ACMG website that contains ACT Sheets, as well as web-analytics data for 
this page. The web-analytics were used to evaluate the number of people accessing the ACT Sheets 
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in each state, compared against the number of people who could be accessing them (the number 
of PCPs in each state and each state’s overall population), as well as to compare peaks in usage 
over time against conferences where individuals from the NCC would have promoted the ACT 
Sheets to conference attendees. The three-question survey was used to assess how frequently 
visitors use the ACT Sheets as well as their satisfaction with the ACT Sheets, including their ability 
to provide desired information in an easy-to-access way, and allowed respondents space to provide 
general feedback on the ACT Sheets. 
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3.0 Methods 
3.1 Institutional Review Board 
This project was determined to not be human subjects research by a representative of the 
University of Pittsburgh Institutional Review Board (communication in Appendix A). 
3.2 Data Set 
Data for this project was provided by the National Coordinating Center for Regional 
Genetics Networks (NCC). It includes data from a brief survey as well as web analytics. 
3.2.1 Survey 
The survey consisted of 3 questions, as outlined in Table 3. There were two multiple choice 
questions and one open-ended question, the latter of which allowed respondents the opportunity 
to share their thoughts and suggestions. These questions were intended to measure general usage 
and satisfaction with the ACT Sheets and Algorithms. 
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Table 3. Questions included in pop-up survey 
Question Response Options 
How easy was it to find the ACMG ACT Sheet and/or 
Algorithm you were seeking? 
Very easy, Easy, Neutral, Difficult, 
Very difficult 
How often (on average) do you access the ACMG 
ACT Sheets and Algorithms? 
Once a week, Once a month, Once a 
year, Less than once a year 
Any other feedback you would like to provide on how 
the ACMG ACT Sheets and Algorithms are displayed 
on the ACMG website? 
Open-ended 
 
Survey responses were collected from August 2018 to May 2019. The survey was 
administered via a pop-up window that appeared upon viewing the ACMG’s main page where all 
of the ACT Sheets and Algorithms are listed. Visitors to the site had the option of closing out of 
the survey without answering the questions if they did not want to answer the survey. The survey 
would pop-up every visit until it was completed, each time with the option of being closed without 
responding. Once the survey was answered, the survey would no longer pop-up for an individual 
using the same computer, limiting the same visitors from responding multiple times. 
3.2.2 Web Analytics 
Web-analytics were pulled from August 2018 to August 2019 for the main page where all 
of the ACT Sheets and Algorithms are listed. The web-analytics included the number of overall 
visits to the site, the number of unique visitors, the number of returning visitors, the number of 
overall page views (the number of times a visitor opened one or more of the ACT Sheets and/or 
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Algorithms), the bounce rate (the rate of people leaving a page immediately after entering it), and 
the geographic location of visitors (broken down by state to include the District of Columbia). The 
total number of visits per month was also pulled for this timeframe and the schedule of conferences 
attended by NCC staff obtained in order to compare trends in ACT Sheet usage over time against 
the timing of promotional activities. 
3.2.3 Demographics 
The target population for this project was PCPs, because this is the population for which 
the ACT Sheets are designed. It is likely that the majority of ACT Sheet users and survey 
respondents are at least medical professionals, even if they are not PCPs, based on such providers 
being the target audience for the ACMG website where the ACT Sheets and survey were posted, 
as well as other websites that link to ACT Sheets such as UpToDate and the National Library of 
Medicine (American College of Medical Genetics and Genomics, 2001; UpToDate, n.d.). This is 
not to say that members of the general population did not access the ACT Sheets during the 
project’s timeframe or complete the survey, especially considering that the NCC advertises the 
ACT Sheets on social media. Ultimately, it is not possible to confirm who visited the website or 
responded to the survey because no questions were asked regarding profession.  
There were no formal inclusion or exclusion criteria. Anyone who visited the website 
during the above-mentioned time periods were able to complete the pop-up survey and were 
automatically included in the web analytics. 
Data on the primary care provider population for each state was obtained from the Total 
Active Patient Care Primary Care Physicians section of the 2019 State Physician Workforce Data 
Report (AAMC, 2019).  This report is published biennially by the American Association of 
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Medical Colleges, making it the most current iteration at the time of data analysis for this project. 
It is intended to provide state-specific data, in addition to data from Puerto Rico and the District 
of Columbia, on both currently practicing physicians as well as medical students and physicians-
in-training to medical program directors, physicians, and policymakers and is free to access for the 
general public. This data will be used as a comparison data set to the location of website visitors 
from the web analytics data to determine estimates for expected proportion of visits to the main 
ACMG ACT Sheets and Algorithms webpage occurring in each state and comparison to the actual 
number of visits.   
3.3 Data Analysis 
3.3.1 Survey 
Data from all three survey questions were compiled, analyzed and used to create pie charts 
and bar graphs using Microsoft Excel (2019). Responses from the two multiple choice questions 
were counted and converted into percentages of overall responses. Thematic analysis was 
conducted by one individual, then reviewed by one additional person experienced in qualitative 
data analysis. Responses from the third, open-ended question were first broken down into general 
themes (Positive, Negative, Mixed, Other) based on whether the response included a suggestion 
for the ACT Sheets and Algorithms (a negative response) or not (a positive response). The number 
of responses in each general theme were counted and converted to percentages. These general 
themes were then further broken down into more specific categories based on the specific 
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suggestions made by the respondents. The number of responses in each specific theme were again 
counted. 
3.3.2 Web Analytics – Usage by State 
Data on the geographic location of visitors to the ACT Sheets and Algorithms main 
webpage was used to assess if the number of people accessing the ACT Sheets and Algorithms in 
each state reflected the distribution of primary care providers across states. This was done by 
creating two scatter plots using StataSE 16.0. The first scatter plot compared the number of visitors 
to the ACT Sheets and Algorithms main web page from each state, against the number of PCPs 
based in each state, for a total of 51 data points. The second scatter plot compared the number of 
visitors to the ACT Sheets and Algorithms main web page from each state, against the total 
population of each state, again, for a total of 51 points. A Spearman’s correlation was also 
calculated for each of these comparisons to assess the degree of relationship between these 
variables.  
Data on the number of overall and unique visits to the ACT Sheets and Algorithms main 
web page were used largely in basic calculations of response rates to the survey. 
3.3.3 Web Analytics – Usage Trends Over Time 
Usage of the ACT Sheets over time was plotted as the number of visits to the ACMG ACT 
Sheet website each month from August 2018 to July 2019 and aligned with the seven conferences 
attended by NCC staff during this time (Table 4). Qualitative assessment of the relationship 
between usage and promotional activities at conferences was conducted. 
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Table 4. Names and timing of conferences attended by NCC Staff between August 2018 and July 2019 
Conference Dates 
American Society of Human Genetics 
(ASHG) 
October 16th-20th, 2018 
American Public Health Association 
(APHA) 
November 9th-15th, 2018  
National Society of Genetic Counselors 
(NSGC) 
November 14th-17th, 2018 
Association of Maternal & Child Health 
Programs (AMCHP) 
March 9th-12th, 2019 
American College of Medical Genetics and 
Genomics (ACMG) 
April 2nd-6th, 2019 
American Public Health Laboratories 
(APHL): Newborn Screening Symposium 
April 7th-10th, 2019 
National Association of County and City 
Health Officials (NACCHO) 








Out of the 8,635 unique visitors to the ACT Sheets and Algorithms main web page (data 
not shown), only 262 responded to the survey. This is a 3.03% overall response rate. 
Question-specific response rates were as follows: 261 out of 262 (99.6%) for the first 
multiple choice question (Figure 1), 257 out of 262 (98.1%) for the second multiple choice 
question (Figure 2), and 144 out of 262 (55%) for the open-ended question (Figure 3, Figure 4). 
4.1.1 Survey Responses  
Forty-four percent of respondents reported that they found it “very easy” to find the ACMG 
ACT Sheet or Algorithm they were looking for, while 29 percent found it “easy,” fifteen percent 





Figure 1. Responses to multiple choice question one 
Eighteen percent of respondents reported that they access the ACMG ACT Sheets and/or 
Algorithms once a week, 38-percent reported that they access them once a month, 20-percent 
reported that they access them once a year, and 24 percent reported that the access them less than 
once a year (Figure 2).  
When the responses indicating accessing these resources once a week or once a month are 











How easy was it to find the ACMG ACT 
sheet and/or algorithm you were seeking? 
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visitors by web-analytics (data not shown). This means approximately 20-percent of return visitors 
completed this question. 
 
Figure 2. Responses to multiple choice question two 
 
For the open-ended question, almost half of respondents commented with no feedback. Of 
the remaining 51-percent of responses, most were either positive, neutral, or negative (Figure 3). 
Positive responses were typically broad, often either offering thanks for the service or generally 
stating that the ACT Sheets were good. Negative feedback included both suggestions and direct 
criticisms, as well as one response that simply stated, “Yes”. Neutral comments were 
predominantly about the survey itself or details about personal usage of the ACT Sheets, and did 
not reflect a positive or negative opinion toward the ACT Sheets. Mixed feedback was defined as 
statements that included both positive and negative connotations, such as, “Hard to get used to and 
find things on new website, looks nice but difficult to use.” Six responses (four-percent) could not 








< Once a year
24%
How often (on average) do you access the 
ACMG ACT sheets and algorithms? 
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Figure 3. General themes produced from responses to the open-ended question 
 
In focusing on coded responses containing feedback, only two responses had specific 
positive comments – one regarding the readability of the ACT Sheets and the other commenting 
on the display. Suggestions on including additional conditions, namely spinal muscular atrophy, 
X-linked adrenoleukodystrophy, hereditary hemochromatosis, mucopolysaccharidosis and other 
inborn errors of metabolism in general were made by five respondents. Alternative formats, such 
as small reference cards, and a need to update more regularly were also mentioned by two and 
three respondents, respectively. Additionally, several respondents focused on the timing of the 
survey – appearing immediately upon visiting the site – or on the fact that this was their first time 
using the site, hinting at the fact that they had not been able to review the ACT Sheets yet due to 













Any other feedback you would like to provide on how 
the ACMG ACT sheets and algorithms are displayed on 
the ACMG website? (General themes)
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It is also important to note that one of the responses indicated that the respondent was a 
parent of a child who was recently diagnosed with a genetic condition who was looking for 
information. This confirms that not all 262 respondents, or 8,635 unique visitors to the main 
ACMG ACT Sheets and Algorithms webpage (data not shown), are primary care providers. The 
only other respondent who described their reason for accessing stated, “I am using them for 
education of graduate nursing students.” 
 
 


























Any other feedback you would like to provide on how 
the ACMG ACT sheets and algorithms are displayed on 
the ACMG website? (Specific themes)
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4.2 Web Analytics – Usage by State 
There were similar trends between usage standardized by population size and by PCP 
population of each state. The District of Columbia had by far the highest usage rate, both when 
comparing usage to overall population size and the number of PCPs. It was followed by states such 
as Vermont, Utah, and West Virginia. Usage in these states are ranked differently when looking at 
overall population and number of PCPs, but they are all in the top three states (not including 





Figure 5. Number of PCPs broken down by location 
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Figure 6. Rate of visits to the ACMG ACT sheets by 100,000 total state population 




















































Number of Visits Per 100,000 Population
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Figure 6 shows a direct linear relationship between the number of visitors to the ACT Sheets and 
Algorithms main web page from each state and the number of PCPs based in each state. 
Similarly, Figure 7 shows a direct linear relationship between the number of visitors to the ACT 
Sheets and Algorithms main web page from each state and the total population of that state. The 
Spearman correlation supported this relationship, with a coefficient of 0.87 (p-value: 0.0001) for 
the relationship between the number of visits and the number of PCPs and 0.85 (p-value: 0.0001) 
for the relationship between the number of visits and total population. 
 
 
Figure 7. Plot of the number of visits from each of the 50 United States and the District of Columbia, against 




Figure 8. Plot of the number of visits from each of the 50 United States and the District of Columbia, against 
the the total population of that location 
 
4.2.1 Web Analytics – Usage Over Time 
Visits to the ACT Sheet website may be closely related to promotional activities at certain 
conferences. The months with the highest usage were October 2018, April 2019, and July 2019, 
all of which included at least one conference attended by NCC staff, while the months of December 




Figure 9. Total number of visits to ACMG ACT Sheets by month from August 2018 to July 2019, including 

































There is currently little literature available regarding usage and design of just-in-time 
resources like the ACMG ACT Sheets and Algorithms. The main finding of note that has been 
previously reported is in regard to the content of just-in-time resources. Harding et al. (2019) 
reported that primary care providers are less interested in learning about the underlying genetic 
mechanisms of a disease than they are in learning about next steps they should take, including 
clinical decision making and referral guidelines (Harding et al., 2019a). This is interesting because 
while the ACT Sheets have a complete, easy to read section on key steps to take, the molecular 
basis of disease is often mentioned as well, suggesting mismatched priorities between genetics 
professionals and PCPs. This is also relevant in the context of one of the responses to the open-
ended survey question, suggesting ordering the ACT Sheets’ content as a “summary [first] and 
then breakdown by types of disorders.” Although it can be argued that having some additional 
information – in this case, the molecular basis of the disease – could provide the benefit of making 
this more detailed information readily available to providers who are interested, it seems that PCPs 
are not likely to need this information for their day-to-day practice. This means that adding this 
kind of detail may take away from the main goal of the ACT Sheets, which is to provide an easy 
to follow, to the point just-in-time resource for PCPs in order to help them care for patients who 
have or are suspected of having a genetic condition. Overall, it is likely that the formatting and 
content of the ACT Sheets may need to be re-evaluated with the preferences of the target audience 
(PCPs) in mind. 
There is also the potential barrier of ease of use, making it important to determine whether 
the ACT Sheets are as easy to use as intended. Harding et al. (2019) reported that primary care 
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providers were generally open to using just-in-time resources, as long as they were easy to access 
(Harding et al., 2019b). In contrast, Scheuner, et al. (2014) found that providers were unlikely to 
click on links to just-in-time resources due to not having sufficient time to review them. However, 
it is important to note that Scheuner, et al. (2014) provided these just-in-time resources as part of 
a toolkit that providers used mostly during patient appointments, when time is even more limited 
than normal (Scheuner et al., 2014). It may be that just-in-time resources that are available at any 
time, like the ACT Sheets, are more feasible for use by primary care providers. This is only true 
though if the website is easy for users to navigate. As shown by the open-ended survey responses 
about difficulties navigating the ACMG website to find the ACT Sheets and responses to the 
survey question directly inquiring about ease of use, this is not the case for everyone who visits 
the ACMG website. It is also worthwhile to note that while only 7.6 percent of respondents 
commented on website problems in their response to the open-ended question (Figure 4), twelve 
percent of respondents reported finding it either “difficult” or “very difficult” to find the ACT 
Sheet or Algorithm they were looking for. This suggests that the problem is larger than suggested 
by the open-ended question responses, especially considering the large percent of survey 
respondents who chose not to answer the open-ended question.  
Harding et al. (2019) also found that PCPs were interested in learning more about specific 
guidelines for making referrals and current reference resources that are available for use (Harding 
et al., 2019b). This is echoed by one of the open-ended responses from this project where a 
respondent asked, “Is there a link to this excellent resource from medical websites that "every" 
physician knows? (eg UpToDate)?” as this suggests that providers – even providers who have 
found the ACT Sheets – may not be aware that the ACT Sheets are in fact available on UpToDate 
as well as other commonly known sites like the National Library of Medicine. It is therefore worth 
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considering how to inform PCPs who may not know the ACT Sheets exist and therefore would 
not know to look for them on commonly used sites such as these. This may be especially true in 
light of only 24-percent of survey respondents stating that they use the ACT Sheets less than once 
a year (Figure 2) – the category that first-time ACT Sheet users would fall under. This means that 
the majority of people (at least 76-percent) who use the ACT Sheets are repeat visitors, raising the 
question of how many additional people could benefit from the ACT Sheets, but have not visited 
because they do not know that these resources exist. 
Just-in-time resources have also been mentioned as a way to provide up-to-date 
information to primary care providers in an easy to access way (Harding et al, 2019). Assuming 
the problems with navigating the ACMG website can be overcome, there is still concern that the 
ACT Sheets are not meeting the expectation of being up-to-date. There were multiple open-ended 
responses that suggested the ACT Sheets needed further updating or review. These responses 
ranged from one respondent simply saying, “Needs updating.” to another commenting more 
specifically, “Update ACT Sheets more frequently, the Alpha Thal sheet is from 10 years ago and 
gives a cutoff of 25% for Barts. Genereviews says 15% hemoglobin Barts should raise concerns 
for HbH disease.” It is critical that reference resources like the ACT Sheets are current in order to 
provide PCPs and other providers with the correct information they need to treat and manage their 
patients.  
Regarding marketing and corresponding usage of the ACT Sheets, it was unclear if there 
is a relationship between promotional activities at conferences and ACT Sheet usage. The three 
months that saw the highest number of visits to the ACMG ACT Sheet website – October 2018, 
April 2019, and July 2019 – all included at least one, if not two conferences attended by NCC 
staff. However, certain months that included one or more conferences saw fewer visits to the 
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ACMG ACT Sheet website than months that did not have any conferences. Namely, November 
2018 and March 2019, during which NCC staff attended two conferences and one conference, 
respectively, saw fewer visits than August 2018, January 2019, February 2019, and May 2019 – 
all months where no conferences were attended. It is also not clear why the months of December 
2018 and June 2019 had the lowest usage of all months between August 2018 and July 2019 
(Figure 8). In the case of December, this decrease could be explained by the numerous holidays, 
potentially impacting the number of patients seen and need for the ACT Sheets, if there were not 
two conferences in November 2018 that should have theoretically carried usage over into 
December. A decrease in June may make more sense due to the impact of summer holidays and 
the fact that there had been over a month since the last conference attended by NCC staff. 
The analysis of usage by states showed also large discrepancies between states for the level 
of usage, although there was a clear and direct relationship between both the number of visits and 
the number of PCPs in a state, as well as the number of visits and the overall state population. This 
poses the question of why certain states, such as Utah and West Virginia, have a higher rate of 
visits to the ACMG ACT Sheets compared to other states such as California. One possible reason 
for this is a higher number of PCPs per 100,000 people. However, this can be ruled out because of 
the wide range of PCP density among the places with the highest usage (DC: 179.4, VT: 121.5, 
UT: 62.2, WV: 89.4) and the lowest usage (WY: 76.2, ID: 68.9, HI: 104.7, ME: 119.7). Notably, 
the locations with the highest number of PCPs per 100,000 people are the District of Columbia, 
Vermont, and Maine (Appendix B), which are split between the highest and the lowest users of 
ACT Sheets. Another possibility could be the degree of marketing to PCPs by each of the regional 




The low survey response rate (3.03%) calls the representativeness of the survey sample 
into question. The representativeness is further threatened considering the target population is 
primary care providers, but one respondent self-identified as a parent looking for information about 
a genetic disorder that their child was recently diagnosed with, and another respondent alluded to 
being a fellow in an unspecified area of medicine. It is therefore possible that the latter individual 
is a genetics fellow, which would make them a clearly not part of the target population. There is 
no way to identify the other 260 respondents’ backgrounds or purposes for visiting the webpage, 
so it is possible, and in fact likely, that there were more non-primary care provider respondents. 
As with the survey, the issue of not being able to identify how many of the visitors are 
primary care providers, calls the representativeness of the web analytics data of the target 
population into question. This is especially true for the geographic analysis because for the 
comparison to the current primary care provider workforce, it was assumed that there was an equal 
percent of PCPs making up the overall percentages of visits from each state. An equitable 
distribution of positive newborn screens was also assumed across states, even though no data was 
able to be found to support this assumption. This is important because if one state has a 
significantly higher rate of positive newborn screens than another state, it may be that primary care 
providers in the state with a higher rate have a reason to access the ACT Sheets and Algorithms 
more often.  
Another key limitation is that all web-analytics were pulled for the main webpage where 
all of the ACT Sheets and Algorithms are listed, instead of being pulled for individual ACT Sheets. 
It may have been more informative to pull the data for individual ACT Sheets as this would have 
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shown which types of ACT Sheets are used more commonly, which would have alluded to what 
ACT Sheets are the most needed or useful.  
5.2 Future Directions 
Marketing of just-in-time resources was also only assessed from the standpoint of 
promotional activities at conferences. This leaves the opportunity for further research on the 
impact of other modes of marketing, such as social media. There is also currently little to no 
literature on the best design and distribution method of just-in-time resources. The survey results 
show that there are in fact aspects of the ACT Sheets that need to be changed, and the geographic 
analysis shows that there is a disconnect between where primary care providers are and where the 
ACT Sheets are being accessed. This warrants further research, potentially in regard to how 
marketing impacts this distribution once that data becomes available. It may also be helpful to 
analyze additional web-analytics data that were not analyzed here, such as bounce rate and number 
of page-specific views. Bounce rate may be especially useful to determine if visitors to the site 
were able to find information that is useful to them and remain on the site or page to read that 
information. This specific focus on bounce rates may be able to further inform why there is an 




In summary, the ACT Sheets generally seem to be received positively by individuals who 
are aware of and reference them. The main areas of improvement, as suggested by respondents to 
the pop-up survey, are in promoting ease of access, structure, and content – including more regular 
updates of the content. There is also a need to improve marketing of the ACT Sheets to providers, 
especially in certain areas of the country. It is unclear whether marketing in the form of 
promotional activities at conferences is the best way to achieve this goal. Lessons could be learned 
regarding marketing by further investigating reasons why certain states, such as West Virginia and 
Utah, have such high rates of ACT Sheet usage compared to many other states. 
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Appendix A IRB Communication 
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Appendix B  Supplementary Data 
Helpful/Good 
No, they are great 
Very helpful 
It is very useful 
I like the way it is 
Great job! 
I think is a very useful tool for genetics practice 
love them 
very helpful information 







with having this information on the web and expertly written states don't have to develop their 




Please stop blocking my view 
Its very difficult to find the sheet that I want with this pop up box in the way. Make your survey 
move off the page until I have completed my task.  
I have not searched yet - your popup to the survey came up before I had a chance to search 
Your survey occurs before I have opened the document 
I just clicked on the website. I think this questionnaire pops up too soon before I have had a 
chance to look at the website for the first time 
Survey popped up before even one sheet located -- no way forward without answering -- 
probably won't net you the data you seek with survey 
this is the first time using and I haven't even gotten on website yet but got this survey 
asking these questions before I've had a chance to search will not provide meaningful answers 




First Time Viewing (but don't mention survey) 
I just logged in for the first time 
I just learned about these and may access them more often now that I'm aware of them 
just joined 
first time here 
 
Website problems 
The new ACMG website is horrible, can't find anything 
Every time I click on the ACT sheet, it prompts a page not found error 
search button 
hard to get used to new website and where things are 
I always end up going back to google and typing ACMG ACT sheets because I don't know where 
to go from the ACMG home page 
responsive web design would be better to present, interactive display may be added 
links are not active 
just having the words ACT Sheets as an option like your old page would be great! 
hard to get used to and find things on new website, looks nice but difficult to use 





Algorithms are clear and easy to follow 




how often are the sheets updated 
Update act sheets more frequently, the Alpha Thal sheet is from 10 years ago and gives a cutoff 




Sheets needed for all conditions on the ACHDNC panel 
Please add SMA, X-ALD, MPS-1 
inborn errors of metabolism 
hh (hereditary hemochromatosis) 
[nutrition] in the patient with inborn error of metabolism. Hepatopathy in the patient with 





summary and then breakdown by types of disorders 
Is there a quick reference card for each screening done for clinicians to have as opposed to 
sheets of paper 
 
Mobile App 
No, but mobile app needs updating to be compatible with newer devices 
update the mobile app to facilitate use in the clinic 
please fix the app if you haven't already. Its crucial for us, specially fellows 
 
International Use 
please try to open courses for overseas candidates 
I am in [South America]. It is of great help to get algorithms for metabolic diseases. Please make 





Is there a link to this excellent resource from medical websites that "every" physician knows? 
(eg UpToDate)? 
send them or put them in a journal for family physician 
it would be excellent if link was shorter (or if a shorter link would redirect to this site). It is hard 
to provide such a long link to others 
outside sites should be able to link to the ACT Sheet 
 
Reason for Accessing 
I am using them for education of graduate nursing students 
no. I'm trying to find help for my son. We've been told he has [a rare] syndrome 
 
Uncoded 
Did not understand that some tests have algorithms and some do not 
BNA 
I was trying to go to the page for Section D (shared methodologies) and ended up on the ACT 
Sheet page instead 












Visits to ACT 
Sheets 








visits per PCP 
AK 737,438 11 105.6 1.492 0.03 
AL 4,887,871 105 71.2 2.148 0.014 
AR 3,013,825 38 75 1.261 0.018 
AZ 7,171,646 96 73.2 1.339 0.017 
CA 39,557,045 73 87.1 1.904 0.022 
CO 5,695,564 85 88.9 1.492 0.016 
CT 3,572,665 134 93.7 3.751 0.04 
DC 702,455 207 179.4 29.468 0.026 
DE 967,171 22 87.2 2.275 0.164 
FL 21,299,325 324 80.1 1.521 0.019 
GA 10,519,475 196 71.9 1.863 0.026 
HI 1,420,491 16 104.7 1.126 0.011 
IA 3,156,145 39 77.9 1.236 0.011 




IL 12,741,080 320 87.2 2.512 0.024 
IN 6,691,878 122 74.4 1.823 0.016 
KS 2,911,505 37 80.5 1.271 0.016 
KY 4,468,402 129 72.9 2.887 0.04 
LA 4,659,978 88 75.8 1.888 0.025 
MA 6,902,149 367 114.6 5.317 0.01 
MD 6,042,718 306 97.6 5.064 0.052 
ME 1,338,404 16 119.7 1.195 0.046 
MI 9,995,915 149 87.6 1.491 0.017 
MN 5,611,179 123 96 2.192 0.023 
MO 6,126,452 174 79 2.84 0.045 
MS 2,986,530 83 61.2 2.779 0.036 
MT 1,062,305 21 88 1.977 0.022 
NC 10,383,620 243 78.1 2.34 0.043 
ND 760,077 16 79.6 2.105 0.021 
NE 1,929,268 67 80.3 3.473 0.021 
NH 1,356,458 28 99.6 2.064 0.0029 
NJ 8,908,520 228 87.5 2.559 0.018 
NM 2,095,428 31 82.1 1.479 0.029 




NY 19,542,209 534 94.8 2.733 0.026 
OH 11,689,442 394 83.7 3.371 0.04 
OK 3,943,079 127 68.5 3.221 0.047 
OR 4,190,713 128 101 3.054 0.03 
PA 12,807,060 373 88.2 2.912 0.033 
RI 1,057,315 34 106.6 3.216 0.03 
SC 5,084,127 158 72.3 3.108 0.043 
SD 882,235 34 84.8 3.853 0.045 
TN 6,770,010 204 77.8 3.013 0.039 
TX 28,701,845 405 66.5 1.411 0.021 
UT 3,161,105 223 62.2 7.054 0.113 
VA 8,517,685 331 81.7 3.886 0.08 
VT 626,299 61 121.5 9.739 0.048 
WA 7,535,591 171 91.7 2.269 0.025 
WI 5,813,568 98 86.4 1.686 0.061 
WV 1,805,832 99 89.4 5.482 0.02 
WY 577,737 4 76.2 0.692 0.009 
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